Q9ES52 (SHIP1_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 101.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 EC=3.1.3.86 Alternative name(s): Inositol polyphosphate-5-phosphatase of 145 kDa Short name=SIP-145 SH2 domain-containing inositol 5'-phosphatase 1 Short name=SH2 domain-containing inositol phosphatase 1 Short name=SHIP-1 p150Ship | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 1191 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. Acts as a negative regulator of B-cell antigen receptor signaling. Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Acts as a negative regulator of myeloid cell proliferation/survival and chemotaxis, mast cell degranulation, immune cells homeostasis, integrin alpha-IIb/beta-3 signaling in platelets and JNK signaling in B-cells. Regulates proliferation of osteoclast precursors, macrophage programming, phagocytosis and activation and is required for endotoxin tolerance. Involved in the control of cell-cell junctions, CD32a signaling in neutrophils and modulation of EGF-induced phospholipase C activity. Key regulator of neutrophil migration, by governing the formation of the leading edge and polarization required for chemotaxis. Modulates FCGR3/CD16-mediated cytotoxicity in NK cells. Mediates the activin/TGF-beta-induced apoptosis through its Smad-dependent expression. May also hydrolyze PtdIns(1,3,4,5)P4, and could thus affect the levels of the higher inositol polyphosphates like InsP6. Ref.1 Ref.11 Ref.13 Ref.23 Ref.24 Ref.25 Ref.26 Ref.32 Ref.34 Ref.35 Ref.37 Ref.38 Ref.39 Ref.40 Ref.41 Ref.42 Ref.45 Ref.48 Ref.51 |
| Catalytic activity | 1-phosphatidyl-1D-myo-inositol 3,4,5-triphosphate + H2O = 1-phosphatidyl-1D-myo-inositol 3,4-diphosphate + phosphate. Ref.1 Ref.2 Ref.19 |
| Enzyme regulation | Activated upon translocation to the sites of synthesis of PtdIns(3,4,5)P3 in the membrane. |
| Subunit structure | Interacts with tyrosine phosphorylated forms of SHC1, DOK1, DOK3, PTPN11/SHP-2, SLAMF1/CD150. Interacts with PTPN11 in response to IL-3. Interacts with receptors EPOR, MS4A2/FCER1B and FCER1G, FCGR2A, FCGR2B and FCGR3. Interacts with GRB2 and PLCG1. Interacts with tyrosine kinases SRC and TEC. Interacts with FCGR2A, leading to regulate gene expression during the phagocytic process. Interacts with c-Met/MET. Interacts with MILR1 (tyrosine-phosphorylated). Isoform 5 interacts with IL6ST/gp130. Can weakly interact (via NPXY motif 2) with DAB2 (via PID domain); the interaction is impaired by tyrosine phosphorylation of the NPXY motif. Ref.1 Ref.2 Ref.4 Ref.14 Ref.15 Ref.16 Ref.17 Ref.18 Ref.20 Ref.27 Ref.28 Ref.29 Ref.30 Ref.31 Ref.33 Ref.36 Ref.37 Ref.40 Ref.43 Ref.44 Ref.45 Ref.46 Ref.49 |
| Subcellular location | Cytoplasm. Cell membrane; Peripheral membrane protein. Note: Translocates to the plasma membrane when activated, translocation is probably due to different mechanisms depending on the stimulus and cell type. Partly translocated via its SH2 domain which mediates interaction with tyrosine phosphorylated receptors such as the FC-gamma-RIIB receptor (FCGR2B) or CD16/FCGR3. Tyrosine phosphorylation may also participate in membrane localization. Ref.21 Ref.36 Ref.47 Isoform 5: Cell membrane; Peripheral membrane protein. Note: Constitutively present at the cell membrane. Ref.21 Ref.36 Ref.47 |
| Tissue specificity | Specifically expressed in immune and hematopoietic cells. Levels vary considerably within this compartment. Lost during erythropoiesis when erythroid cells become Ter119+. Increases substantially with T-cell maturation and when resting B-cells are activated. Also present in mature granulocytes, monocyte/macrophages, mast cells and platelets. Isoform 5 is the only form expressed in embryonic stem (ES) cells and is coexpressed with other isoforms in hematopoietic stem cells, and disappears with differentiation. Ref.1 Ref.2 Ref.4 Ref.22 |
| Developmental stage | Expressed in late primitive-streak stage embryos (7.5 dpc), when hematopoiesis is thought to begin, and the expression is restricted to the hematopoietic lineage in embryo. In adults expression continues to be in the majority of cells from hematopoietic origin, including granulocytes, monocytes and lymphocytes, and is also found in the spermatids of the testis. Ref.4 Ref.22 |
| Induction | By activin/TGF-beta (at protein level). Regulated by the Smad pathway. Isoform 3 is expressed during myeloid development. Ref.38 |
| Domain | The SH2 domain interacts with tyrosine phosphorylated forms of proteins such as SHC1 or PTPN11/SHP-2. It competes with that of GRB2 for binding to phosphorylated SHC1 to inhibit the Ras pathway. It is also required for tyrosine phosphorylation. Ref.14 The NPXY sequence motif found in many tyrosine-phosphorylated proteins is required for the specific binding of the PID domain. Ref.14 |
| Post-translational modification | Tyrosine phosphorylated by the members of the SRC family after exposure to a diverse array of extracellular stimuli such as cytokines, growth factors, antibodies, chemokines, integrin ligands and hypertonic and oxidative stress. Phosphorylated upon IgG receptor FCGR2B-binding. Ref.1 Ref.4 Ref.12 Ref.15 Ref.27 Ref.29 Ref.37 |
| Disruption phenotype | Mice are viable and fertile. They however fail to thrive and only 40% survive by 14 weeks of age. Mortality is associated with extensive consolidation of the lungs resulting from infiltration by myeloid cells. Increased numbers of granulocyte-macrophage progenitors are observed in both the bone marrow and spleen. Absence of Inpp5d leads to steel factor-induced degranulation of mast cells. They also display increased numbers of osteoclast precursors leading to a severe osteoporosis. Ref.23 Ref.26 Ref.39 |
| Sequence similarities | Belongs to the inositol 1,4,5-trisphosphate 5-phosphatase family. Contains 1 SH2 domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| PIK3R1 | P23727 | 2 | EBI-1452545,EBI-520244 | From a different organism. |
| Plcg2 | Q8CIH5 | 3 | EBI-300210,EBI-617954 |
Alternative products
| This entry describes 6 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9ES52-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9ES52-2) The sequence of this isoform differs from the canonical sequence as follows: 120-120: Missing. | ||||||
| Isoform 3 (identifier: Q9ES52-3) Also known as: 135 kDa SHIP; The sequence of this isoform differs from the canonical sequence as follows: 920-980: Missing. | ||||||
| Isoform 4 (identifier: Q9ES52-4) Also known as: SHIPdelta; The sequence of this isoform differs from the canonical sequence as follows: 120-120: Missing. 920-960: GMGPFGQPLH...DSSLGPGRGE → VFIFHSQPRS...GPAADEARDV 961-1191: Missing. | ||||||
| Note: May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. | ||||||
| Isoform 5 (identifier: Q9ES52-5) Also known as: s-SHIP; The sequence of this isoform differs from the canonical sequence as follows: 1-263: Missing. | ||||||
| Isoform 6 (identifier: Q9ES52-6) Also known as: s-SHIPD183; The sequence of this isoform differs from the canonical sequence as follows: 1-263: Missing. 920-980: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1191 | 1191 | Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 | PRO_0000302867 | |||||
Regions | |||||||||
| Domain | 8 – 104 | 97 | SH2 | ||||||
| Region | 1015 – 1029 | 15 | Interaction with DAB2 | ||||||
| Motif | 127 – 132 | 6 | SH3-binding 1 | ||||||
| Motif | 915 – 918 | 4 | NPXY motif 1 | ||||||
| Motif | 970 – 975 | 6 | SH3-binding 2 | ||||||
| Motif | 1018 – 1021 | 4 | NPXY motif 2 | ||||||
| Motif | 1039 – 1050 | 12 | SH3-binding 3 | ||||||
| Compositional bias | 962 – 1153 | 192 | Pro-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 868 | 1 | Phosphotyrosine Ref.50 Ref.52 | ||||||
| Modified residue | 918 | 1 | Phosphotyrosine Ref.15 | ||||||
| Modified residue | 935 | 1 | Phosphoserine Ref.50 | ||||||
| Modified residue | 945 | 1 | Phosphotyrosine Ref.50 | ||||||
| Modified residue | 972 | 1 | Phosphoserine Ref.52 | ||||||
| Modified residue | 1021 | 1 | Phosphotyrosine Ref.15 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 263 | 263 | Missing in isoform 5 and isoform 6. | VSP_027980 | |||||
| Alternative sequence | 120 | 1 | Missing in isoform 2 and isoform 4. | VSP_027981 | |||||
| Alternative sequence | 920 – 980 | 61 | Missing in isoform 3 and isoform 6. | VSP_027982 | |||||
| Alternative sequence | 920 – 960 | 41 | GMGPF…PGRGE → VFIFHSQPRSLPQGARGKTW GSGKGGSSAPGGPAADEARD V in isoform 4. | VSP_027983 | |||||
| Alternative sequence | 961 – 1191 | 231 | Missing in isoform 4. | VSP_027984 | |||||
Experimental info | |||||||||
| Mutagenesis | 676 | 1 | D → G: Loss of function. Ref.32 | ||||||
| Mutagenesis | 918 | 1 | Y → F: Strongly impairs function, tyrosine phosphorylation, subcellular location and interaction with DOK1; when associated with F-1021. Ref.15 Ref.32 Ref.33 | ||||||
| Mutagenesis | 1021 | 1 | Y → F: Strongly impairs function, tyrosine phosphorylation, subcellular location and interaction with DOK1; when associated with F-918. Ref.15 Ref.32 Ref.33 | ||||||
| Sequence conflict | 43 | 1 | Y → C in AAB18937. Ref.2 | ||||||
| Sequence conflict | 527 | 1 | V → A in AAC53023. Ref.3 | ||||||
| Sequence conflict | 534 | 1 | N → I in AAC53023. Ref.3 | ||||||
| Sequence conflict | 905 | 1 | C → E AA sequence Ref.2 | ||||||
| Sequence conflict | 981 | 1 | A → T in AAB18937. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity." Lioubin M.N., Algate P.A., Tsai S., Carlberg K., Aebersold A., Rohrschneider L.R. Genes Dev. 10:1084-1095(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), PROTEIN SEQUENCE OF 2-9 AND 1163-1173, FUNCTION, ENZYME ACTIVITY, PHOSPHORYLATION, TISSUE SPECIFICITY, INTERACTION WITH SHC1. Strain: DBA/2. |
| [2] | "The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase." Damen J.E., Liu L., Rosten P., Humphries R.K., Jefferson A.B., Majerus P.W., Krystal G. Proc. Natl. Acad. Sci. U.S.A. 93:1689-1693(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), PROTEIN SEQUENCE OF 902-916, ENZYME ACTIVITY, TISSUE SPECIFICITY, INTERACTION WITH GRB2 AND SHC1. |
| [3] | "Molecular cloning and chromosomal localization in human and mouse of the SH2-containing inositol phosphatase, INPP5D (SHIP)." Liu Q., Dumont D.J. Genomics 39:109-112(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [4] | "A novel spliced form of SH2-containing inositol phosphatase is expressed during myeloid development." Lucas D.M., Rohrschneider L.R. Blood 93:1922-1933(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), PHOSPHORYLATION, INTERACTION WITH SHC1 AND GRB2, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. Strain: BALB/c. |
| [5] | "Cloning of the genomic locus of mouse SH2 containing inositol 5-phosphatase (SHIP) and a novel 110-kDa splice isoform, SHIPdelta." Wolf I., Lucas D.M., Algate P.A., Rohrschneider L.R. Genomics 69:104-112(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 4). Strain: 129/Sv. |
| [6] | "Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein." Tu Z., Ninos J.M., Ma Z., Wang J.-W., Lemos M.P., Desponts C., Ghansah T., Howson J.M., Kerr W.G. Blood 98:2028-2038(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5). |
| [7] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Strain: C57BL/6J. Tissue: Spleen. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Thyroid. |
| [9] | "Analysis of lipopolysaccharide-response genes in B-lineage cells demonstrates that they can have differentiation stage-restricted expression and contain SH2 domains." Kerr W.G., Heller M., Herzenberg L.A. Proc. Natl. Acad. Sci. U.S.A. 93:3947-3952(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-106. |
| [10] | "Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2." Kavanaugh W.M., Pot D.A., Chin S.M., Deuter-Reinhard M., Jefferson A.B., Norris F.A., Masiarz F.R., Cousens L.S., Majerus P.W., Williams L.T. Curr. Biol. 6:438-445(1996) [PubMed] [Europe PMC] [Abstract] Cited for: PARTIAL PROTEIN SEQUENCE. |
| [11] | "Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB." Ono M., Bolland S., Tempst P., Ravetch J.V. Nature 383:263-266(1996) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [12] | "Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP." Chacko G.W., Tridandapani S., Damen J.E., Liu L., Krystal G., Coggeshall K.M. J. Immunol. 157:2234-2238(1996) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION. |
| [13] | "Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling." Ono M., Okada H., Bolland S., Yanagi S., Kurosaki T., Ravetch J.V. Cell 90:293-301(1997) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [14] | "The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis." Liu L., Damen J.E., Hughes M.R., Babic I., Jirik F.R., Krystal G. J. Biol. Chem. 272:8983-8988(1997) [PubMed] [Europe PMC] [Abstract] Cited for: DOMAIN SH2, INTERACTION WITH SHC1. |
| [15] | "Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP." Lamkin T.D., Walk S.F., Liu L., Damen J.E., Krystal G., Ravichandran K.S. J. Biol. Chem. 272:10396-10401(1997) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT TYR-918 AND TYR-1021, INTERACTION WITH SHC1, MUTAGENESIS OF TYR-918 AND TYR-1021. |
| [16] | "Interleukin-3 induces the association of the inositol 5-phosphatase SHIP with SHP2." Liu L., Damen J.E., Ware M.D., Krystal G. J. Biol. Chem. 272:10998-11001(1997) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PTPN11. |
| [17] | "Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2." Morris S.M., Cooper J.A. Traffic 2:111-123(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DAB2. |
| [18] | "An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions." Hitomi K., Tahara-Hanaoka S., Someya S., Fujiki A., Tada H., Sugiyama T., Shibayama S., Shibuya K., Shibuya A. Nat. Immunol. 11:601-607(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MILR1. |
| [19] | "Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets." Giuriato S., Payrastre B., Drayer A.L., Plantavid M., Woscholski R., Parker P., Erneux C., Chap H. J. Biol. Chem. 272:26857-26863(1997) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME ACTIVITY. |
| [20] | "The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors." Sattler M., Salgia R., Shrikhande G., Verma S., Choi J.-L., Rohrschneider L.R., Griffin J.D. Oncogene 15:2379-2384(1997) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PTPN11. |
| [21] | "Multiple forms of the SH2-containing inositol phosphatase, SHIP, are generated by C-terminal truncation." Damen J.E., Liu L., Ware M.D., Ermolaeva M., Majerus P.W., Krystal G. Blood 92:1199-1205(1998) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [22] | "The SH2-containing inositol polyphosphate 5-phosphatase, ship, is expressed during hematopoiesis and spermatogenesis." Liu Q., Shalaby F., Jones J., Bouchard D., Dumont D.J. Blood 91:2753-2759(1998) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. |
| [23] | "Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells." Huber M., Helgason C.D., Scheid M.P., Duronio V., Humphries R.K., Krystal G. EMBO J. 17:7311-7319(1998) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE. |
| [24] | "The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling." Liu Q., Oliveira-Dos-Santos A.J., Mariathasan S., Bouchard D., Jones J., Sarao R., Kozieradzki I., Ohashi P.S., Penninger J.M., Dumont D.J. J. Exp. Med. 188:1333-1342(1998) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [25] | "The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation." Huber M., Helgason C.D., Damen J.E., Liu L., Humphries R.K., Krystal G. Proc. Natl. Acad. Sci. U.S.A. 95:11330-11335(1998) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [26] | "Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span." Helgason C.D., Damen J.E., Rosten P., Grewal R., Sorensen P., Chappel S.M., Borowski A., Jirik F., Krystal G., Humphries R.K. Genes Dev. 12:1610-1620(1998) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE. |
| [27] | "Role of SHIP in FcgammaRIIb-mediated inhibition of Ras activation in B cells." Tridandapani S., Phee H., Shivakumar L., Kelley T.W., Coggeshall K.M. Mol. Immunol. 35:1135-1146(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SHC1 AND FCGR2B, PHOSPHORYLATION. |
| [28] | "pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets." Giuriato S., Bodin S., Erneux C., Woscholski R., Plantavid M., Chap H., Payrastre B. Biochem. J. 348:107-112(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SRC. |
| [29] | "The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor." Mason J.M., Beattie B.K., Liu Q., Dumont D.J., Barber D.L. J. Biol. Chem. 275:4398-4406(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EPOR, PHOSPHORYLATION. |
| [30] | "Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcgamma RIIB." Bruhns P., Vely F., Malbec O., Fridman W.H., Vivier E., Daeeron M. J. Biol. Chem. 275:37357-37364(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FCGR2B. |
| [31] | "Essential role for the C-terminal noncatalytic region of SHIP in FcgammaRIIB1-mediated inhibitory signaling." Aman M.J., Walk S.F., March M.E., Su H.-P., Carver D.J., Ravichandran K.S. Mol. Cell. Biol. 20:3576-3589(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FCGR2B. |
| [32] | "SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation." Damen J.E., Ware M.D., Kalesnikoff J., Hughes M.R., Krystal G. Blood 97:1343-1351(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF ASP-676; TYR-918 AND TYR-1021. |
| [33] | "SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL." Sattler M., Verma S., Pride Y.B., Salgia R., Rohrschneider L.R., Griffin J.D. J. Biol. Chem. 276:2451-2458(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DOK1 AND CRKL, MUTAGENESIS OF TYR-918 AND TYR-1021. |
| [34] | "Src homology 2 domain-containing inositol 5-phosphatase 1 mediates cell cycle arrest by FcgammaRIIB." Malbec O., Schmitt C., Bruhns P., Krystal G., Fridman W.H., Daeeron M. J. Biol. Chem. 276:30381-30391(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [35] | "A regulatory role for Src homology 2 domain-containing inositol 5'-phosphatase (SHIP) in phagocytosis mediated by Fc gamma receptors and complement receptor 3 (alpha(M)beta(2); CD11b/CD18)." Cox D., Dale B.M., Kashiwada M., Helgason C.D., Greenberg S. J. Exp. Med. 193:61-71(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [36] | "SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells." Galandrini R., Tassi I., Mattia G., Lenti L., Piccoli M., Frati L., Santoni A. Blood 100:4581-4589(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, INTERACTION WITH FCGR3. |
| [37] | "Src homology 2 domain-containing inositol polyphosphate phosphatase regulates NF-kappa B-mediated gene transcription by phagocytic Fc gamma Rs in human myeloid cells." Tridandapani S., Wang Y., Marsh C.B., Anderson C.L. J. Immunol. 169:4370-4378(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH FCGR2A, PHOSPHORYLATION. |
| [38] | "Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP." Valderrama-Carvajal H., Cocolakis E., Lacerte A., Lee E.-H., Krystal G., Ali S., Lebrun J.-J. Nat. Cell Biol. 4:963-969(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INDUCTION. |
| [39] | "SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts." Takeshita S., Namba N., Zhao J.J., Jiang Y., Genant H.K., Silva M.J., Brodt M.D., Helgason C.D., Kalesnikoff J., Rauh M.J., Humphries R.K., Krystal G., Teitelbaum S.L., Ross F.P. Nat. Med. 8:943-949(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE. |
| [40] | "The SH2-containing inositol 5-phosphatase (SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells." Mancini A., Koch A., Wilms R., Tamura T. Oncogene 21:1477-1484(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH MET. |
| [41] | "The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity." Baran C.P., Tridandapani S., Helgason C.D., Humphries R.K., Krystal G., Marsh C.B. J. Biol. Chem. 278:38628-38636(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [42] | "SHIP1 and Lyn kinase negatively regulate integrin alpha IIb beta 3 signaling in platelets." Maxwell M.J., Yuan Y., Anderson K.E., Hibbs M.L., Salem H.H., Jackson S.P. J. Biol. Chem. 279:32196-32204(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [43] | "Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap." Isnardi I., Lesourne R., Bruhns P., Fridman W.H., Cambier J.C., Daeeron M. J. Biol. Chem. 279:51931-51938(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FCGR2B. |
| [44] | "SHIP family inositol phosphatases interact with and negatively regulate the Tec tyrosine kinase." Tomlinson M.G., Heath V.L., Turck C.W., Watson S.P., Weiss A. J. Biol. Chem. 279:55089-55096(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TEC. |
| [45] | "Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3." Robson J.D., Davidson D., Veillette A. Mol. Cell. Biol. 24:2332-2343(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH DOK3. |
| [46] | "Inositol 5'-phosphatase, SHIP1 interacts with phospholipase C-gamma1 and modulates EGF-induced PLC activity." Song M., Kim M.J., Ha S., Park J.B., Ryu S.H., Suh P.-G. Exp. Mol. Med. 37:161-168(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PLCG1. |
| [47] | "The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation." Isnardi I., Bruhns P., Bismuth G., Fridman W.H., Daeeron M. Immunol. Lett. 104:156-165(2006) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [48] | "SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27." Zhou P., Kitaura H., Teitelbaum S.L., Krystal G., Ross F.P., Takeshita S. J. Immunol. 177:8777-8784(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [49] | "s-SHIP associates with receptor complexes essential for pluripotent stem cell growth and survival." Desponts C., Ninos J.M., Kerr W.G. Stem Cells Dev. 15:641-646(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH IL6ST. |
| [50] | "Quantitative time-resolved phosphoproteomic analysis of mast cell signaling." Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y., Kawakami T., Salomon A.R. J. Immunol. 179:5864-5876(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-868; SER-935 AND TYR-945, MASS SPECTROMETRY. Tissue: Mast cell. |
| [51] | "Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1." Nishio M., Watanabe K., Sasaki J., Taya C., Takasuga S., Iizuka R., Balla T., Yamazaki M., Watanabe H., Itoh R., Kuroda S., Horie Y., Foerster I., Mak T.W., Yonekawa H., Penninger J.M., Kanaho Y., Suzuki A., Sasaki T. Nat. Cell Biol. 9:36-44(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [52] | "The phagosomal proteome in interferon-gamma-activated macrophages." Trost M., English L., Lemieux S., Courcelles M., Desjardins M., Thibault P. Immunity 30:143-154(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-868 AND SER-972, MASS SPECTROMETRY. Tissue: Macrophage. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U51742 mRNA. Translation: AAC52606.1. U39203 mRNA. Translation: AAB18937.1. U52044 mRNA. Translation: AAC53023.1. AF125996 mRNA. Translation: AAD37118.1. AF235502 AF235501 Genomic DNA. Translation: AAG23922.1.AF228679 mRNA. Translation: AAF69143.1. AF184912 mRNA. Translation: AAF25823.1. AF184913 mRNA. Translation: AAF25824.1. AK143560 mRNA. Translation: BAE25436.1. BC108328 mRNA. Translation: AAI08329.1. |
| IPI | IPI00120516. IPI00124504. IPI00856529. IPI00857008. IPI00857200. IPI00857938. |
| PIR | JC6118. |
| RefSeq | NP_001103662.1. NM_001110192.1. NP_001103663.1. NM_001110193.1. NP_034696.2. NM_010566.2. |
| UniGene | Mm.15105. |
3D structure databases | |
| HSSP | HSSP built from PDB template 1QAD based on UniProtKB P23727. |
| ProteinModelPortal | Q9ES52. |
| SMR | Q9ES52. Positions 3-152, 405-717. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9ES52. 9 interactions. |
| MINT | MINT-205819. |
PTM databases | |
| PhosphoSite | Q9ES52. |
Proteomic databases | |
| PaxDb | Q9ES52. |
| PRIDE | Q9ES52. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000042275; ENSMUSP00000044647; ENSMUSG00000026288. ENSMUST00000072999; ENSMUSP00000072763; ENSMUSG00000026288. ENSMUST00000167032; ENSMUSP00000126569; ENSMUSG00000026288. ENSMUST00000168783; ENSMUSP00000131244; ENSMUSG00000026288. ENSMUST00000169754; ENSMUSP00000127941; ENSMUSG00000026288. ENSMUST00000170300; ENSMUSP00000132384; ENSMUSG00000026288. |
| GeneID | 16331. |
| KEGG | mmu:16331. |
| UCSC | uc007bxc.2. mouse. uc007bxd.2. mouse. uc007bxf.2. mouse. uc007bxg.2. mouse. uc007bxh.2. mouse. |
Organism-specific databases | |
| CTD | 3635. |
| MGI | MGI:107357. Inpp5d. |
Phylogenomic databases | |
| eggNOG | COG5411. |
| GeneTree | ENSGT00700000104142. |
| HOVERGEN | HBG106726. |
| InParanoid | Q9ES52. |
| KO | K03084. |
| OMA | TREKYAY. |
| OrthoDB | EOG4M397X. |
Gene expression databases | |
| ArrayExpress | Q9ES52. |
| Bgee | Q9ES52. |
| CleanEx | MM_INPP5D. |
| Genevestigator | Q9ES52. |
Family and domain databases | |
| Gene3D | 3.30.505.10. 1 hit. |
| InterPro | IPR005135. Endo/exonuclease/phosphatase. IPR000300. IPPc. IPR000980. SH2. [Graphical view] |
| Pfam | PF03372. Exo_endo_phos. 1 hit. PF00017. SH2. 1 hit. [Graphical view] |
| PRINTS | PR00401. SH2DOMAIN. |
| SMART | SM00128. IPPc. 1 hit. SM00252. SH2. 1 hit. [Graphical view] |
| SUPFAM | SSF56219. Exo_endo_phos. 1 hit. |
| PROSITE | PS50001. SH2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 289418. |
| SOURCE | Search... |
Entry information
| Entry name | SHIP1_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q9ES52 Secondary accession number(s): Q3UPF9 Q9WUC2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Recent format changes Overview of recent format changes |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
